Asset Details
Do you wish to reserve the book?
Immune response induced by a Streptococcus suis multi-serotype autogenous vaccine used in sows to protect post-weaned piglets
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Immune response induced by a Streptococcus suis multi-serotype autogenous vaccine used in sows to protect post-weaned piglets
Do you wish to request the book?
Immune response induced by a Streptococcus suis multi-serotype autogenous vaccine used in sows to protect post-weaned piglets
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Immune response induced by a Streptococcus suis multi-serotype autogenous vaccine used in sows to protect post-weaned piglets
2024
Overview
Streptococcus suis
is a bacterial pathogen that causes important economic losses to the swine industry worldwide. Since there are no current commercial vaccines, the use of autogenous vaccines applied to gilts/sows to enhance transfer of passive immunity is an attractive alternative to protect weaned piglets. However, there is no universal standardization in the production of autogenous vaccines and the vaccine formulation may be highly different among licenced manufacturing laboratories. In the present study, an autogenous vaccine that included
S. suis
serotypes 2, 1/2, 5, 7 and 14 was prepared by a licensed laboratory and administrated to gilts using a three-dose program prior to farrowing. The antibody response in gilts as well as the passive transfer of antibodies to piglets was then evaluated. In divergence with previously published data with an autogenous vaccine produced by a different company, the increased response seen in gilts was sufficient to improve maternal antibody transfer to piglets up to 5 weeks of age. However, piglets would still remain susceptible to
S. suis
disease which often appears during the second part of the nursery period. Vaccination did not affect the shedding of
S. suis
(as well as that of the specific
S. suis
serotypes included in the vaccine) by either gilts or piglets. Although all antibiotic treatments were absent during the trial, the clinical protective effect of the vaccination program with the autogenous vaccine could not be evaluated, since limited
S. suis
cases were present during the trial, confirming the need for a complete evaluation of the clinical protection that must include laboratory confirmation of the aetiological agent involved in the presence of
S. suis
-associated clinical signs. Further studies to evaluate the usefulness of gilt/sow vaccination with autogenous vaccines to protect nursery piglets should be done.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ bacterin
/ Ethylenediaminetetraacetic acid
/ Female
/ gilts
/ Immunity, Maternally-Acquired
/ Medicine
/ multiserotype autogenous vaccines
/ sows
/ Streptococcal Infections - immunology
/ Streptococcal Infections - prevention & control
/ Streptococcal Infections - veterinary
/ Streptococcal Vaccines - administration & dosage
/ Streptococcal Vaccines - immunology
/ Streptococcus suis - immunology
/ Swine
/ Swine Diseases - microbiology
/ Swine Diseases - prevention & control
/ Vaccines
/ Veterinary Medicine/Veterinary Science
/ Virology
